Skip to Main Content

Author Details

Guang Fan
Oregon Health and Science University
2000
59
17
PMIDPaper TitleJournal TitlePublished Year
37199721Patient-Specific Targeting of the T-Cell Receptor Variable Region as a Therapeutic Strategy in Clonal T-Cell Diseases.Clin Cancer Res2023
37685882Cytogenetically Cryptic Acute Promyelocytic Leukemia: A Diagnostic Challenge.Int J Mol Sci2023
34482403Identification and prioritization of myeloid malignancy germline variants in a large cohort of adult patients with AML.Blood2022
37552730Community-Based SARS-CoV-2 Testing Using Saliva or Nasopharyngeal Swabs to Compare the Performance of Weekly COVID-19 Screening to Wastewater SARS-CoV-2 Signals.ACS ES T Water2022
35802949A novel heptasomy 21 associated with complete loss of heterozygosity and loss of function RUNX1 mutation in acute myeloid leukemia.Cancer Genet2022
35380701T-cell Dysfunction upon Expression of MYC with Altered Phosphorylation at Threonine 58 and Serine 62.Mol Cancer Res2022
35885487Myelodysplastic Syndrome: Diagnosis and Screening.Diagnostics (Basel)2022
35884893PD-1/PD-L1 Pathway: A Therapeutic Target in CD30+ Large Cell Lymphomas.Biomedicines2022
36008543Bimodal distribution pattern associated with the PCR cycle threshold (Ct) and implications in COVID-19 infections.Sci Rep2022
35258401Adult acute myeloid leukemia patients with <i>NUP98</i> rearrangement have frequent cryptic translocations and unfavorable outcome.Leuk Lymphoma2022
35254096Using Spike Gene Target Failure to Estimate Growth Rate of the Alpha and Omicron Variants of SARS-CoV-2.J Clin Microbiol2022
33089525A novel somatic PLCG2 variant associated with resistance to BTK and SYK inhibition in chronic lymphocytic leukemia.Eur J Haematol2021
33901720Engrafted Donor-Derived Clonal Hematopoiesis after Allogenic Hematopoietic Cell Transplantation is Associated with Chronic Graft-versus-Host Disease Requiring Immunosuppressive Therapy, but no Adverse Impact on Overall Survival or Relapse.Transplant Cell Ther2021
33870648Clinical applications of monitoring immune status with 90 immune cell subsets in human whole blood by 10-color flow cytometry.Int J Lab Hematol2021
34559205In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported.Blood Adv2021
34611480NEDD8-activating enzyme inhibition induces cell cycle arrest and anaphase catastrophe in malignant T-cells.Oncotarget2021
34431689Comparison of SARS-CoV-2 PCR-Based Detection Using Saliva or Nasopharyngeal Swab Specimens in Asymptomatic Populations.Microbiol Spectr2021
32126021<i>GAA</i> compound heterozygous mutations associated with autophagic impairment cause cerebral infarction in Pompe disease.Aging (Albany NY)2020
35846098Biclonal plasma cell leukemia associated with a complex karyotype, TP53 deletion, and high-risk disease.EJHaem2020
31866570Molecular Discordance between Myeloid Sarcomas and Concurrent Bone Marrows Occurs in Actionable Genes and Is Associated with Worse Overall Survival.J Mol Diagn2020
32242922Mast cell sarcoma with concurrent mast cell leukaemia.Br J Haematol2020
32513686Reversible suppression of T cell function in the bone marrow microenvironment of acute myeloid leukemia.Proc Natl Acad Sci U S A2020
31145495The combination of NPM1, DNMT3A, and IDH1/2 mutations leads to inferior overall survival in AML.Am J Hematol2019
31754026Differentiation of leukemic blasts is not completely blocked in acute myeloid leukemia.Proc Natl Acad Sci U S A2019
31738840Primary cutaneous Epstein-Barr virus-positive diffuse large B-cell lymphoma (DLBCL) in a patient taking fingolimod.Dermatol Online J2019
31124175Next-generation sequencing-defined minimal residual disease before stem cell transplantation predicts acute myeloid leukemia relapse.Am J Hematol2019
28868942MYC immunohistochemical and cytogenetic analysis are required for identification of clinically relevant aggressive B cell lymphoma subtypes.Leuk Lymphoma2018
30052721Trends in Bone Marrow Sampling and Core Biopsy Specimen Adequacy in the United States and Canada: A Multicenter Study.Am J Clin Pathol2018
28990859Hematoxylin Bodies in Pediatric Bone Marrow Aspirates and their Utility in the Diagnosis of Systemic Lupus Erythematosus.Pediatr Dev Pathol2018
29199519Outcomes of DA-EPOCH-R induction plus autologous transplant consolidation for double hit lymphoma.Leuk Lymphoma2018
29165010DNMT3A co-mutation is required for FLT3-ITD as an adverse prognostic indicator in intermediate-risk cytogenetic group AML.Leuk Lymphoma2018
27761930Concurrent STAT3, DNMT3A, and TET2 mutations in T-LGL leukemia with molecularly distinct clonal hematopoiesis of indeterminate potential.Am J Hematol2017
27124934Targeted Next-Generation Sequencing in Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia Aids Diagnosis in Challenging Cases and Identifies Frequent Spliceosome Mutations in Transformed Acute Myeloid Leukemia.Am J Clin Pathol2016
26119982The Corepressor Rcor1 Is Essential for Normal Myeloerythroid Lineage Differentiation.Stem Cells2015
26231802MYD88 mutation analysis of a rare composite chronic lymphocyte leukemia and lymphoplasmacytic lymphoma by flow cytometry cell sorting.Ann Hematol2015
24652990Corepressor Rcor1 is essential for murine erythropoiesis.Blood2014
25125625Aberrations of MYC are a common event in B-cell prolymphocytic leukemia.Am J Clin Pathol2014
24637335Functional integration of acute myeloid leukemia into the vascular niche.Leukemia2014
23087056Kinase pathway dependence in primary human leukemias determined by rapid inhibitor screening.Cancer Res2013
24319570Diffuse large B-cell lymphoma in adults aged 75 years and older: a single institution analysis of cause-specific survival and prognostic factors.Ther Adv Hematol2013
23836506Mutations in γ adducin are associated with inherited cerebral palsy.Ann Neurol2013
23278912Early precursor T-lymphoblastic leukaemia/lymphoma arising from paediatric chronic myeloid leukaemia - unusual lymph node blast crisis.Br J Haematol2013
22035377RAS mutations in therapy-related acute myeloid leukemia after successful treatment of acute promyelocytic leukemia.Leuk Lymphoma2012
22658276Multiplex high-throughput gene mutation analysis in acute myeloid leukemia.Hum Pathol2012
22425895Newly described activating JAK3 mutations in T-cell acute lymphoblastic leukemia.Leukemia2012
21502425Association of JAK2 mutation status and cytogenetic abnormalities in myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms.Am J Clin Pathol2011
19801969Nuclear expression of sox11 is highly associated with mantle cell lymphoma but is independent of t(11;14)(q13;q32) in non-mantle cell B-cell neoplasms.Mod Pathol2010
20959657Immunophenotypic correlation between skin biopsy and peripheral blood findings in mycosis fungoides.Am J Clin Pathol2010
20551277Immunophenotypic variations of Burkitt lymphoma.Am J Clin Pathol2010
18237230A unique case of adolescent CD56-negative extranodal NK/T-cell lymphoma, nasal type.Pediatr Dev Pathol2008
  • 1 - 50 of 59

Recommended Authors

The University of Texas MD Anderson Cancer Center
Career Start Year 2011
Number of shared co-authors 0
University of Washington
Career Start Year 2010
Number of shared co-authors 3
Yale School of Medicine
Career Start Year 2010
Number of shared co-authors 0
Vanda Pharmaceuticals Inc.
Career Start Year 2010
Number of shared co-authors 1
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2009
Number of shared co-authors 0
Children's Hospital of Los Angeles
Career Start Year 2008
Number of shared co-authors 3
Hospital Israelita Albert Einstein
Career Start Year 2007
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 3
INSERM U7, Universite Paris-Saclay
Career Start Year 2004
Number of shared co-authors 0
Intermountain Medical Center
Career Start Year 2001
Number of shared co-authors 0
St. Jude Children's Research Hospital
Career Start Year 2000
Number of shared co-authors 3
Tuen Mun Hospital
Career Start Year 1999
Number of shared co-authors 0
Washington University School of Medicine in St. Louis
Career Start Year 1998
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 1996
Number of shared co-authors 3
Mayo Clinic
Career Start Year 1995
Number of shared co-authors 4
University of Paris
Career Start Year 1993
Number of shared co-authors 3
Kyoto University
Career Start Year 1993
Number of shared co-authors 3
Hematology and Clinical Immunology, Heinrich Heine University Dusseldorf
Career Start Year 1992
Number of shared co-authors 1
Johns Hopkins University School of Medicine
Career Start Year 1992
Number of shared co-authors 2
Lille University Hospital, INSERM UMR-S7, CNRS UMR9020, Lille University.
Career Start Year 1989
Number of shared co-authors 0
University of Texas MD Anderson Cancer Center
Career Start Year 1989
Number of shared co-authors 2
Fred Hutchinson Cancer Research Center
Career Start Year 1989
Number of shared co-authors 5
Toronto General Hospital, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 4
Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year 1984
Number of shared co-authors 3
Taussig Cancer Institute, Cleveland Clinic
Career Start Year 1983
Number of shared co-authors 4
University of Utah
Career Start Year 1982
Number of shared co-authors 1
Brigham and Women's Hospital and Harvard Medical School
Career Start Year 1982
Number of shared co-authors 1
Institute for Biomedical Research August Pi I Sunyer
Career Start Year 1981
Number of shared co-authors 3
Center for Cancer Research, National Cancer Institute
Career Start Year 1981
Number of shared co-authors 3
National Cancer Institute, National Institutes of Health
Career Start Year 1981
Number of shared co-authors 4

Collaborators

Oregon Health & Science University
Co-authored papers 18
Oregon Health and Science University
Co-authored papers 14
Oregon Health & Science University
Co-authored papers 7
Knight Cancer Institute, Oregon Health and Science University
Co-authored papers 6
Oregon Health & Science University School of Medicine
Co-authored papers 6
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 6
Oregon Health & Science University
Co-authored papers 5
Oregon Health & Science University
Co-authored papers 5
Oregon Health & Science University, University of California Berkeley
Co-authored papers 5
Oregon Health & Science University
Co-authored papers 5
Oregon Health & Science University
Co-authored papers 5
Oregon Health & Science University
Co-authored papers 3
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
Oregon Health and Science University
Co-authored papers 3
Oregon Health & Science University
Co-authored papers 3
Oregon Health & Science University
Co-authored papers 3
Oregon Health and Science University
Co-authored papers 2
Vollum Institute, Oregon Health and Science University
Co-authored papers 2
Xinhua Hospital, Shanghai Jiaotong University of Medicine School
Co-authored papers 2
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Oregon Health and Science University
Co-authored papers 2
Oregon Health and Science University
Co-authored papers 2
Association for Molecular Pathology
Co-authored papers 2
Vollum Institute, Oregon Health & Science University
Co-authored papers 2
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
University of Utah Huntsman Cancer Institute
Co-authored papers 2
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Co-authored papers 2
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Oregon Health & Science University
Co-authored papers 2
Oregon Health and Science University
Co-authored papers 2